Purchase Order 75D30122P13528
Award Date 4/14/22
Potential Completion Date 5/30/22
Potential Value $120K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $160,160 firm fixed-price purchase order to Perfinity Biosciences, Inc., a small disadvantaged business, for the delivery of Perfinity trypsin-immobilized liquid chromatography columns. The columns are necessary for the CDC's Clinical Chemistry Branch to operate its Perfinity Workstations and perform protein analysis for its laboratory and other projects. There was no set-aside designation for this unrestricted procurement. Perfinity...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Promega Corporation, a global life sciences company, to provide 1,400 vials of Promega Trypsin Gold, Mass Spectrometry Grade, for $107,800.00. The trypsin is needed for protein digestion to determine the concentration of hemoglobin adducts of formaldehyde in the U.S. population as part of the CDC's biomonitoring activities performed in compliance with CLIA...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Phenomenex, Inc., a for-profit manufacturer of chromatography columns and laboratory supplies, for the delivery of STRATA-X-AW-WELL PLATES. The award, valued at $121,500.00, was made on March 30, 2020 with a completion date of June 4, 2020. No set-aside was used for this contract. Phenomenex is a prime contractor that has fulfilled multiple delivery orders for...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Preomics Inc., a foreign-owned, self-certified small disadvantaged business, to procure the PreOmics PreON proteomics liquid handling system for automated sample preparation. This $104,000 sole-source contract was awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b) and 10 U.S.C. 2304(c)(1). The CDC's Biomedical and Chemical...
- This is a $38,213 firm-fixed-price purchase order contract awarded to Proteos Inc. by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of laboratory supplies, with a period of performance running through September 29, 2024. Proteos Inc. is a for-profit organization that specializes in producing high-quality recombinant proteins, including HIV-related proteins, which are critical for the CDC's disease prevention and control activities....
- This is a $54,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company that provides protein mass spectrometry and proteomics services. The contract, identified as MS BIOWORKS MSB-DIA-03, is for an ultimate completion date of July 30, 2024. Based on the vendor's past federal contract awards, the services to be provided under this contract likely include quantitative proteomics analysis,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $65,791 firm fixed-price purchase order contract to Purigen Biosystems, Inc., a for-profit manufacturer, on September 30, 2021. The contract, which has a period of performance through September 29, 2025, is not associated with a larger vehicle and does not have a set-aside designation. The contract appears to be for the provision of biosystems-related products or services, though specific details on the requested items are not...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $121,577.21 firm-fixed-price purchase order to Biotage, LLC, a manufacturer of analytical chemistry equipment and consumables, for the delivery of specialized laboratory supplies and equipment. The award, which did not have a set-aside designation, was based on a pre-solicitation for "Isolute/Evolute Plates and Columns" posted on January 22, 2019, with a due date of January...
- The Centers for Disease Control and Prevention (CDC) awarded a $72,715 firm-fixed-price purchase order to Phenomenex, Inc., a manufacturer of chromatography columns and laboratory supplies, for the acquisition of Strata-X-AW 33 μm polymeric weak anion 60 mg/well, 96-well plates. This award is not associated with any set-aside designation. Phenomenex, a subsidiary of Danaher Corporation, is a trusted supplier of specialized analytical testing equipment to various federal agencies, including the...
- The Centers for Disease Control and Prevention (CDC) awarded Sino Biological US Inc., a foreign-owned small disadvantaged business and manufacturer of goods, a $249,050 firm fixed-price purchase order for protein production to support viral disease prevention and control efforts. The award has no set-aside designation. In addition to this prime federal contract, Sino Biological has received awards from other agencies such as the National Institutes of Health (NIH) for generating materials to aid...
The Department of Health and Human Services' Centers for Disease Control and Prevention awarded a $120,080 firm-fixed price purchase order to Perfinity Biosciences, Inc. for the delivery of trypsin columns. Perfinity Biosciences is a small disadvantaged business that manufactures goods for protein sample preparation used in mass spectrometric analysis. This award is the latest in a series of purchase orders the CDC has issued to Perfinity for trypsin columns and immobilized trypsin columns since 2019, totaling over $234,000. The contract did not involve any set-aside designations.
Generated 3/22/24, 3:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $120.1k | 4/14/22 |